Combined PET/MRI: Global Warming—Summary Report of the 6th International Workshop on PET/MRI, March 27–29, 2017, Tübingen, Germany

[1]  R. Gillies,et al.  Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer , 2016, Science Translational Medicine.

[2]  B. Gückel,et al.  Combined PET/MRI: Multi-modality Multi-parametric Imaging Is Here , 2015, Molecular Imaging and Biology.

[3]  T. Fehm,et al.  Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. , 2014, The Lancet. Oncology.

[4]  B. Sheu,et al.  Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole‐body PET/MR: Correlation with pathological prognostic factors , 2015, Journal of magnetic resonance imaging : JMRI.

[5]  M. Aichler,et al.  Immuno-PET Imaging of Engineered Human T Cells in Tumors. , 2016, Cancer research.

[6]  H. Quick,et al.  Magnetic Resonance–Based Attenuation Correction for PET/MR Hybrid Imaging Using Continuous Valued Attenuation Maps , 2013, Investigative radiology.

[7]  Harald H Quick,et al.  Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging , 2015, Investigative radiology.

[8]  Yu-Ting Chang,et al.   PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  S. Leger,et al.  FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  R. Boellaard,et al.  Technical and instrumentational foundations of PET/MRI. , 2017, European journal of radiology.

[11]  W. Heiss,et al.  The potential of PET/MR for brain imaging , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  A. Alavi,et al.  Oncogene pathway activation in mammary tumors dictates FDG-PET uptake. , 2014, Cancer research.

[13]  G. V. von Schulthess,et al.  PET/MR Outperforms PET/CT in Suspected Occult Tumors , 2017, Clinical nuclear medicine.

[14]  R. Boellaard,et al.  Repeatability of 18F-FDG PET in a Multicenter Phase I Study of Patients with Advanced Gastrointestinal Malignancies , 2009, Journal of Nuclear Medicine.

[15]  M. Forsting,et al.  Integrated PET/MRI for whole-body staging of patients with primary cervical cancer: preliminary results , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  A. S. Brandt,et al.  Erratum to: 18F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  C. Dodge,et al.  Assessment of Sequential PET/MRI in Comparison With PET/CT of Pediatric Lymphoma: A Prospective Study. , 2016, AJR. American journal of roentgenology.

[18]  J. Han,et al.  Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study , 2016, European Radiology.

[19]  J. Clohessy,et al.  Pro-senescence therapy for cancer treatment , 2011, Nature Reviews Cancer.

[20]  Osama Sabri,et al.  PET/MR in dementia and other neurodegenerative diseases. , 2015, Seminars in nuclear medicine.

[21]  A. Buck,et al.  Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT , 2015, BMC Cancer.

[22]  Edward Hsiao,et al.  Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance , 2017, Theranostics.

[23]  F. Schick,et al.  Simultaneous PET-MRI reveals brain function in activated and resting state on metabolic, hemodynamic and multiple temporal scales , 2013, Nature Medicine.

[24]  Ciprian Catana,et al.  Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI , 2013, Proceedings of the National Academy of Sciences.

[25]  Maurizio Conti,et al.  Simultaneous Reconstruction of Activity and Attenuation in Time-of-Flight PET , 2012, IEEE Transactions on Medical Imaging.

[26]  H. Quick,et al.  Field of view extension and truncation correction for MR-based human attenuation correction in simultaneous MR/PET imaging. , 2014, Medical physics.

[27]  Robert D. Stevens,et al.  Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma Patients , 2015, Tomography.

[28]  Marianne Patt,et al.  Fully automated calculation of image-derived input function in simultaneous PET/MRI in a sheep model , 2016, EJNMMI Physics.

[29]  Johan Nuyts,et al.  ML-reconstruction for TOF-PET with simultaneous estimation of the attenuation factors , 2014, 2012 IEEE Nuclear Science Symposium and Medical Imaging Conference Record (NSS/MIC).

[30]  Sanjay K. Jain.  The Promise of Molecular Imaging in the Study and Treatment of Infectious Diseases , 2017, Molecular Imaging and Biology.

[31]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[32]  V. Saini,et al.  A Systematic Approach for Developing Bacteria-Specific Imaging Tracers , 2017, The Journal of Nuclear Medicine.

[33]  F. Real,et al.  Intratumour heterogeneity in urologic cancers: from molecular evidence to clinical implications. , 2015, European urology.

[34]  A. Wetter,et al.  Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI , 2016, PloS one.

[35]  D. Lee,et al.  Effect of Peptide Receptor Radionuclide Therapy on Somatostatin Receptor Status and Glucose Metabolism in Neuroendocrine Tumors: Intraindividual Comparison of Ga-68 DOTANOC PET/CT and F-18 FDG PET/CT , 2011, International journal of molecular imaging.

[36]  M. Schwaiger,et al.  Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer. , 2016, European urology.

[37]  P. Lambin,et al.  Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[38]  H H Quick,et al.  Towards improved hardware component attenuation correction in PET/MR hybrid imaging , 2013, Physics in medicine and biology.

[39]  Daniel Paech,et al.  Fast and Quantitative T1ρ-weighted Dynamic Glucose Enhanced MRI , 2017, Scientific Reports.

[40]  Kyoungjune Pak,et al.  Clinical Implication of PET/MR Imaging in Preoperative Esophageal Cancer Staging: Comparison with PET/CT, Endoscopic Ultrasonography, and CT , 2014, The Journal of Nuclear Medicine.

[41]  K. Brindle.  Imaging metabolism with hyperpolarized (13)C-labeled cell substrates. , 2015, Journal of the American Chemical Society.

[42]  D. M. Lyons,et al.  Evaluation of σ-1 Receptor Radioligand 18F-FTC-146 in Rats and Squirrel Monkeys Using PET , 2014, The Journal of Nuclear Medicine.

[43]  F. Schick,et al.  Simultaneous PET/MR imaging of the brain: feasibility of cerebral blood flow measurements with FAIR-TrueFISP arterial spin labeling MRI , 2012, Acta radiologica.

[44]  R. Gillies,et al.  A unifying theory of carcinogenesis, and why targeted therapy doesn't work. , 2012, European journal of radiology.

[45]  Junming Shao,et al.  Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study , 2016, The Journal of Nuclear Medicine.

[46]  J. Ardenkjær-Larsen,et al.  Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Gil Navon,et al.  Functional molecular imaging of tumors by chemical exchange saturation transfer MRI of 3‐O‐Methyl‐D‐glucose , 2014, Magnetic resonance in medicine.

[48]  Patrick Dupont,et al.  Simultaneous maximum a posteriori reconstruction of attenuation and activity distributions from emission sinograms , 1999, IEEE Transactions on Medical Imaging.

[49]  Sergios Gatidis,et al.  Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. , 2014, Radiology.

[50]  J. Bulte,et al.  In vivo multicolor molecular MR imaging using diamagnetic chemical exchange saturation transfer liposomes , 2012, Magnetic resonance in medicine.

[51]  Jeong Yeon Cho,et al.  Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT , 2017, Journal of magnetic resonance imaging : JMRI.

[52]  Kristian Bredies,et al.  Joint MR-PET Reconstruction Using a Multi-Channel Image Regularizer , 2017, IEEE Transactions on Medical Imaging.

[53]  J. Han,et al.  Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer. , 2016, European journal of radiology.

[54]  V. Sossi,et al.  Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15–19, 2016; Tübingen, Germany , 2016, Molecular Imaging and Biology.

[55]  Ciprian Catana,et al.  Imaging Agonist-Induced D2/D3 Receptor Desensitization and Internalization In Vivo with PET/fMRI , 2016, Neuropsychopharmacology.

[56]  Nirbhay N. Yadav,et al.  Chemical exchange saturation transfer (CEST): What is in a name and what isn't? , 2011, Magnetic resonance in medicine.

[57]  R. Boellaard,et al.  Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17–21, 2014, Tübingen, Germany , 2015, Molecular Imaging and Biology.

[58]  Harald H Quick,et al.  Hybrid Positron Emission Tomography/Magnetic Resonance Imaging: Challenges, Methods, and State of the Art of Hardware Component Attenuation Correction , 2016, Investigative radiology.

[59]  Tetsuro Sekine,et al.  Effect of Time-of-Flight Information on PET/MR Reconstruction Artifacts: Comparison of Free-breathing versus Breath-hold MR-based Attenuation Correction. , 2017, Radiology.

[60]  A. S. Brandt,et al.  18F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[61]  B. Rosen,et al.  Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients , 2016, Abdominal Radiology.

[62]  M. Pomper,et al.  Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography , 2014, Science Translational Medicine.

[63]  James D. Brenton,et al.  Liquid biopsies come of age: towards implementation of circulating tumour DNA , 2017, Nature Reviews Cancer.

[64]  M. Forsting,et al.  18F-FDG PET/MRI in patients suffering from lymphoma: how much MRI information is really needed? , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[65]  Ciprian Catana,et al.  PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype , 2017, British Journal of Cancer.

[66]  R. Hicks,et al.  PET/MRI: a different spin from under the rim , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[67]  P. Heusch,et al.  Malignant pleural mesothelioma: initial experience in integrated (18)F-FDG PET/MR imaging. , 2016, Clinical imaging.

[68]  Mark F. Lythgoe,et al.  In vivo imaging of glucose uptake and metabolism in tumors , 2012, Nature Medicine.

[69]  Anneleen Daemen,et al.  Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors , 2015, Proceedings of the National Academy of Sciences.

[70]  Hisataka Kobayashi,et al.  Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules , 2011, Nature Medicine.

[71]  Soon-Young Song,et al.  J Korean Surg Soc 2011;81:104-110 DOI: 10.4174/jkss.2011.81.2.104 ORIGINAL ARTICLE , 2022 .

[72]  M. Roethke,et al.  Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[73]  G. Zaharchuk,et al.  Biodistribution and Radiation Dosimetry of 18F-FTC-146 in Humans , 2017, The Journal of Nuclear Medicine.

[74]  R. Boellaard,et al.  Summary Report of the First International Workshop on PET/MR Imaging, March 19–23, 2012, Tübingen, Germany , 2013, Molecular Imaging and Biology.

[75]  K. Brindle,et al.  Potential Clinical Roles for Metabolic Imaging with Hyperpolarized [1-13C]Pyruvate , 2016, Front. Oncol..

[76]  Michael Forsting,et al.  Implementation of FAST-PET/MRI for whole-body staging of female patients with recurrent pelvic malignancies: A comparison to PET/CT. , 2015, European journal of radiology.

[77]  R. Boellaard,et al.  Combined PET/MR: Where Are We Now? Summary Report of the Second International Workshop on PET/MR Imaging April 8–12, 2013, Tubingen, Germany , 2014, Molecular Imaging and Biology.